Esperion Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ESPR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -22.63 M-31.42 M-4.29 M45.24 M-27.72 M -18.19 M Cash from investing activities 0000-189 K -189 K Cash from financing activities -7.5 M2.85 M10.67 M30.16 M16.22 M 59.9 M Free cash flow -22.63 M-31.42 M-4.29 M45.24 M-27.72 M -18.19 M

News

Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?

Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?

Epilogue On Esperion Therapeutics Stock (NASDAQ:ESPR)

ESPR Stock Surges 44% in a Month: Here's What You Need to Know

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

BofA reiterates Esperion Therapeutics stock Underperform rating

Bempedoic acid gains top-level guideline recommendations for cholesterol

Citizens raises Esperion Therapeutics price target on drug growth

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

H.C. Wainwright reiterates Buy on Esperion stock, $16 target

Esperion Q4 2025 slides: 38% sales growth, $4.6B CHF opportunity